Publications

  1. Bian X, Conley SM, Eirin A, Zimmerman Zuckerman EA, Smith AL, Gowan CC, Snow ZK, Jarmi T, Farres H, Erben YM, Hakaim AG, Dietz MA, Zubair AC, Wyles SP, Wolfram JV, Lerman LO, Hickson LJ. Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells. Stem Cell Res Ther. 2023 Mar 22; 14 (1):49
    View PubMed
  2. Korchak JA, Wiest EF, Zubair AC. How do we assess batch-to-batch consistency between extracellular vesicle products? Transfusion. 2023 Feb; 63 (2):279-287 Epub 2022 Nov 03
    View PubMed
  3. Erasmus DB, Durand N, Alvarez FA, Narula T, Hodge DO, Zubair AC. Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients. Stem Cells Transl Med. 2022 Sep 21; 11 (9):891-899
    View PubMed
  4. Liu HD, Su L, Winters JL, Thibodeaux SR, Park YA, Wu Y, Schwartz J, Zubair AC, Schneiderman J, Gupta GK, Ramakrishnan S, Aqui NA. Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis. Cytotherapy. 2022 Sep; 24 (9):916-922 Epub 2022 Apr 06
    View PubMed
  5. Ramos-Fresnedo A, Perez-Vega C, Domingo RA, Lee SJ, Perkerson RB, Zubair AC, Takahisa K, Tatum W, Quinones-Hinojosa A, Middlebrooks EH, Grewal SS. Mesenchymal stem cell therapy for focal epilepsy: A systematic review of preclinical models and clinical studies. Epilepsia. 2022 Jul; 63(7):1607-1618. Epub 2022 May 11.
    View PubMed
  6. Thibodeaux SR, Aqui NA, Park YA, Schneiderman J, Su LL, Winters JL, Zubair AC, Schwartz J, Liu HD, Immune Effector Cell Therapy Subcommittee, Clinical Applications Committee, American Society for Apheresis. Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies. J Clin Apher. 2022 Jun; 37 (3):223-236 Epub 2022 Jan 27
    View PubMed
  7. Durand N, Zubair AC. Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons. Surgery. 2022 May; 171 (5):1440-1442 Epub 2021 Dec 01
    View PubMed
  8. Avila FR, Torres-Guzman RA, Huayllani MT, Guliyeva G, Zubair AC, Quiñones-Hinojosa A, Forte AJ, Sarabia-Estrada R. Human stem cells prevent flap necrosis in preclinical animal models: A systematic review. J Clin Transl Res. 2022 Apr 29; 8(2):110-124. Epub 2022 Mar 01.
    View PubMed
  9. Huang P, Zhang C, Delawary M, Korchak JA, Suda K, Zubair AC. Development and evaluation of IL-6 overexpressing mesenchymal stem cells (MSCs). J Tissue Eng Regen Med. 2022 Mar; 16 (3):244-253 Epub 2021 Dec 19
    View PubMed
  10. Korchak JA, Delawary M, Huang P, Zhang C, Suda K, Zubair AC. Endothelial nitric oxide synthase-engineered mesenchymal stromal cells induce anti-inflammation in experimental immune models. Cytotherapy. 2022 Mar; 24 (3):262-271 Epub 2021 Nov 23
    View PubMed
  11. Garcia JP, Avila FR, Torres RA, Maita KC, Eldaly AS, Rinker BD, Zubair AC, Forte AJ, Sarabia-Estrada R. Hypoxia-preconditioning of human adipose-derived stem cells enhances cellular proliferation and angiogenesis: A systematic review. J Clin Transl Res. 2022 Feb 25; 8 (1):61-70 Epub 2022 Jan 25
    View PubMed
  12. Torres-Guzman RA, Huayllani MT, Avila FR, Maita K, Zubair AC, Quinones-Hinojosa A, Sarabia-Estrada R, Forte AJ. Application of Human Adipose-Derived Stem cells for Bone Regeneration of the Skull in Humans. J Craniofac Surg. 2022 Jan-Feb 01; 33(1):360-363.
    View PubMed
  13. Zhang C, Delawary M, Huang P, Korchak JA, Suda K, Zubair AC. IL-10 mRNA Engineered MSCs Demonstrate Enhanced Anti-Inflammation in an Acute GvHD Model. Cells. 2021 Nov 10; 10 (11)
    View PubMed
  14. Nguyen JH, Jiang LJ, Kang L, Malik S, Orlando C, Zubair A, Rehman FK. Intranodal Sirolimus Induces Regulatory T Cells in Human Hepatic Lymph Nodes via Interleukin 10 Signaling. Liver Transpl. 2021 Nov; 27 (11):1669-1672 Epub 2021 July 31
    View PubMed
  15. Fricova D, Korchak JA, Zubair AC. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease. NPJ Regen Med. 2020 Nov 3; 5 (1):20 Epub 2020 Nov 03
    View PubMed
  16. Wiest EF, Zubair AC. Challenges of manufacturing mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine. Cytotherapy. 2020 Nov; 22 (11):606-612 Epub 2020 June 10
    View PubMed
  17. Durand N, Mallea J, Zubair AC. Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure. NPJ Regen Med. 2020 Oct 26; 5 (1):17
    View PubMed
  18. Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, Caplan AI, Kurtzberg J, Zubair AC, Kubrova E, Engelberg-Cook E, Nayfeh T, Shah VP, Hill JC, Wolf ME, Prokop LJ, Murad MH, Sanfilippo FP. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med. 2020 Sep; 9 (9):1007-1022 Epub 2020 May 29
    View PubMed
  19. Walker SA, Aguilar Diaz De Leon JS, Busatto S, Wurtz GA, Zubair AC, Borges CR, Wolfram J. Glycan Node Analysis of Plasma-Derived Extracellular Vesicles. Cells. 2020 Aug 22; 9 (9)
    View PubMed
  20. Zahra K, Turnbull MT, Zubair AC, Siegel JL, Venegas-Borsellino CP, Tawk RG, Freeman WD. A Combined Approach to Intracerebral Hemorrhage: Intravenous Mesenchymal Stem Cell Therapy with Minimally Invasive Hematoma Evacuation. J Stroke Cerebrovasc Dis. 2020 Aug; 29 (8):104931 Epub 2020 May 30
    View PubMed
  21. Huang P, Russell AL, Lefavor R, Durand NC, James E, Harvey L, Zhang C, Countryman S, Stodieck L, Zubair AC. Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application. NPJ Microgravity. 2020 Jun 1; 6 (1):16 Epub 2020 June 01
    View PubMed
  22. Jamali SA, Turnbull MT, Kanekiyo T, Vishnu P, Zubair AC, Raper CC, Tawk RG, Freeman WD. Elevated Neutrophil-Lymphocyte Ratio is Predictive of Poor Outcomes Following Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis. 2020 Apr; 29 (4):104631 Epub 2020 Jan 18
    View PubMed
  23. Huang P, Russell AL, Lefavor R, Durand NC, James E, Harvey L, Zhang C, Countryman S, Stodieck L, Zubair AC. Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application. NPJ Microgravity. 2020; 6:16 Epub 2020 June 01
    View PubMed
  24. Bakeer M, Zubair AC, Roy V. Low baseline platelet count predicts poor response to plerixafor in patients with multiple myeloma undergoing autologous stem cell mobilization. Cytotherapy. 2020 Jan; 22 (1):16-20 Epub 2019 Dec 24
    View PubMed
  25. Shapiro SA, Arthurs JR, Heckman MG, Bestic JM, Kazmerchak SE, Diehl NN, Zubair AC, O'Connor MI. Quantitative T2 MRI Mapping and 12-Month Follow-up in a Randomized, Blinded, Placebo Controlled Trial of Bone Marrow Aspiration and Concentration for Osteoarthritis of the Knees. Cartilage. 2019 Oct; 10 (4):432-443 Epub 2018 Aug 30
    View PubMed
  26. Shapiro SA, Arthurs JR, Heckman MG, Bestic JM, Diehl NN, Zubair AC, O'Connor MI. Response to Letter to the Editor. Cartilage. 2019 Oct; 10 (4):506-507 Epub 2019 July 11
    View PubMed
  27. Vega M, Zubair A, Perry D, Fritz A, Chadha R. Liver Transplantation in a Patient With Anti-Co(a) Antibodies. Prog Transplant. 2019 Sep; 29 (3):287-288 Epub 2019 June 05
    View PubMed
  28. Suh A, Pham A, Cress MJ, Pincelli T, TerKonda SP, Bruce AJ, Zubair AC, Wolfram J, Shapiro SA. Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation. Ageing Res Rev. 2019 Sep; 54:100933. Epub 2019 Jun 24.
    View PubMed
  29. Kharfan-Dabaja MA, Jain MD, Aulakh S, Ayala E, Zubair AC, Tun HW, Liu HD, Locke FL, Chavez JC. Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells. Am J Hematol 2019 Sep; 94 (9):E245-E247 Epub 2019 June 18
    View PubMed
  30. Durand N, Russell A, Zubair AC. Effect of Comedications and Endotoxins on Mesenchymal Stem Cell Secretomes, Migratory and Immunomodulatory Capacity. J Clin Med. 2019 Apr 11; 8 (4)
    View PubMed
  31. Huang P, Freeman WD, Edenfield BH, Brott TG, Meschia JF, Zubair AC. Safety and Efficacy of Intraventricular Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in Hemorrhagic Stroke Model. Sci Rep. 2019 Apr 5; 9 (1):5674 Epub 2019 Apr 05
    View PubMed
  32. Azzouqa AM, Jouni K, Roy V, Zubair AC. Impact of good and poor mobilizers on hematopoietic progenitor cell collection efficiency and product quality. J Clin Apher. 2019 Feb; 34 (1):39-43 Epub 2018 Nov 14
    View PubMed
  33. Turnbull MT, Zubair AC, Meschia JF, Freeman WD. Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research. NPJ Regen Med. 2019; 4:10 Epub 2019 May 13
    View PubMed
  34. Russell AL, Lefavor RC, Zubair AC. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications. Transfusion. 2018 Oct; 58 (10):2374-2382 Epub 2018 Sept 10
    View PubMed
  35. Keller CA, Gonwa TA, Russell AL, Hodge DO, Erasmus DB, Zubair AC. Preliminary Report on the Effect of Mesenchymal Stem Cell Therapy in Patients With Chronic Allograft Dysfunction Stem Cells Transl Med. 2018.
  36. Russell AL, Lefavor R, Durand N, Glover L, Zubair AC. Modifiers of mesenchymal stem cell quantity and quality. Transfusion. 2018 Jun; 58 (6):1434-1440 Epub 2018 Mar 26
    View PubMed
  37. Lightner AL, Wang Z, Zubair AC, Dozois EJ. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions. Dis Colon Rectum. 2018 May; 61 (5):629-640
    View PubMed
  38. Keller CA, Gonwa TA, Hodge DO, Hei DJ, Centanni JM, Zubair AC. Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction. Stem Cells Transl Med. 2018 Feb; 7 (2):161-167 Epub 2018 Jan 11
    View PubMed
  39. Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O'Connor MI. A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. Am J Sports Med. 2017 Jan; 45 (1):82-90 Epub 2016 Sept 30
    View PubMed
  40. Jiang P, Huang P, Yen SH, Zubair AC, Dickson DW. Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis. Cytotherapy. 2016 Dec; 18 (12):1483-1492 Epub 2016 Oct 06
    View PubMed
  41. Zubair AC, Torp K, Eichbaum Q. How we provide blood transfusion support in two large US liver transplant programs. Transfusion. 2016 Aug; 56 (8):1938-43 Epub 2016 June 24
    View PubMed
  42. Haji S, Planchard R, Zubair A, Graff-Radford J, Rydberg C, Brown RD Jr, Flemming KD. The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation. J Neurol. 2016 Feb; 263 (2):238-244 Epub 2015 Nov 14
    View PubMed
  43. Russell A, Malik S, Litzow M, Gastineau D, Roy V, Zubair AC. Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment. Transfusion. 2015 Jul; 55(7):1758-65; quiz 1757. Epub 2015 Mar 11.
    View PubMed
  44. Eldjerou LK, Cogle CR, Rosenau EH, Lu X, Bennett CA, Sugrue MW, Hoyne J, Lambert A, Ashley L, Sazama K, Fields G, Wingard JR, Zubair AC. Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and Caucasians. Transfusion. 2015 Jul; 55 (7):1766-71 Epub 2015 Apr 22
    View PubMed
  45. Haga H, Yan IK, Takahashi K, Wood J, Zubair A, Patel T. Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth. J Extracell Vesicles. 2015; 4:24900 Epub 2015 Jan 02
    View PubMed
  46. Zubair A. Therapeutic phlebotomy. Clin Liver Dis (Hoboken). 2014 Nov; 4 (5):102-106 Epub 2014 Dec 09
    View PubMed
  47. Huang P, Gebhart N, Richelson E, Brott TG, Meschia JF, Zubair AC. Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. Cytotherapy. 2014 Oct; 16 (10):1336-44 Epub 2014 June 11
    View PubMed
  48. Festic E, Rabinstein AA, Freeman WD, Mauricio EA, Robinson MT, Mandrekar J, Zubair AC, Lee AS, Gajic O. Blood transfusion is an important predictor of hospital mortality among patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2013 Apr; 18 (2):209-15
    View PubMed
  49. Jiang L, Malik S, Litzow M, Gastineau D, Micallef I, Roy V, Solberg L, Zubair AC. Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent. Transfusion. 2012 Mar; 52 (3):542-8 Epub 2011 Aug 09
    View PubMed
  50. Torloni AS, Lumadue J, Zubair A. Therapeutic apheresis: when things go wrong. J Clin Apher. 2012; 27(3):168-71. Epub 2012 Apr 16.
    View PubMed
  51. Vishnu P, Roy V, Paulsen A, Zubair AC. Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization. Transfusion. 2012 Jan; 52 (1):55-62 Epub 2011 June 09
    View PubMed
  52. Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, Lincoln SJ, Lepretre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Melrose HL, Behrouz B, Keeling BH, Bacon JA, Hentati E, Williams L, Yanagiya A, Sonenberg N, Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska-Wajs A, Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Destee A, Farrer MJ. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet. 2011 Sep 9; 89 (3):398-406
    View PubMed
  53. Hellinger WC, Heckman MG, Crook JE, Taner CB, Willingham DL, Diehl NN, Zubair AC, Shalev JA, Nguyen JH. Association of surgeon with surgical site infection after liver transplantation. Am J Transplant. 2011 Sep; 11 (9):1877-84 Epub 2011 Aug 09
    View PubMed
  54. Zubair AC, Malik S, Paulsen A, Ishikawa M, McCoy C, Adams PX, Amrani D, Costa M. Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells. Cytotherapy. 2010 Apr; 12 (2):178-89
    View PubMed
  55. Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 2010 Feb; 24 (2):548-59 Epub 2009 Oct 13
    View PubMed
  56. Zubair AC. Clinical impact of blood storage lesions. Am J Hematol. 2010 Feb; 85 (2):117-22
    View PubMed
  57. Hellinger WC, Crook JE, Heckman MG, Diehl NN, Shalev JA, Zubair AC, Willingham DL, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB. Surgical site infection after liver transplantation: risk factors and association with graft loss or death. Transplantation. 2009 May 15; 87 (9):1387-93
    View PubMed
  58. Zubair AC, Rymer R, Young J, Keeton U, Befort R, Nolot B, Evans C, Bleach T, Torloni A. Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants. J Clin Apher. 2009; 24 (1):6-11
    View PubMed
  59. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion. 2008 Jun; 48 (6):1106-14 Epub 2008 Feb 25
    View PubMed
  60. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood. 2008 Mar 15; 111 (6):3200-10 Epub 2008 Jan 09
    View PubMed
  61. Dietz AB, Bulur PA, Emery RL, Winters JL, Epps DE, Zubair AC, Vuk-Pavlovic S. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion. 2006 Dec; 46 (12):2083-9
    View PubMed
  62. Zubair AC, Kao G, Daley H, Schott D, Freedman A, Ritz J. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation. Cytotherapy. 2006; 8 (4):399-407
    View PubMed
  63. Zubair AC, Zahrieh D, Daley H, Schott D, Gribben JG, Alyea EP, Schlossman R, Freedman A, Antin JH, Soiffer RJ, Neuberg D, Ritz J. Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy. Transfusion. 2004 Feb; 44 (2):253-61
    View PubMed
  64. Zubair A, Zahrieh D, Daley H, Schott D, Gribben JG, Freedman A, Ritz J. Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution. Transfusion. 2003 May; 43 (5):614-21
    View PubMed
  65. Zubair AC, Silberstein L, Ritz J. Adult hematopoietic stem cell plasticity. Transfusion. 2002 Aug; 42(8):1096-101.
    View PubMed
  66. Zubair A, Benjamin RJ. Transfusion medicine illustrated. Erythrophagocytosis after an ABO-mismatched stem cell transplant. Transfusion. 2001 Dec; 41(12):1463.
    View PubMed
  67. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol. 2001 Dec 1; 167(11):6471-9.
    View PubMed
  68. Mata M, Yao ZJ, Zubair A, Syres K, Paterson Y. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge. Vaccine. 2001 Jan 8; 19(11-12):1435-45.
    View PubMed
  69. Zubair AC, Ali SA, Rees RC, Goepel JR, Goyns MH. Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice. Cancer Lett. 1996 Oct 1; 107(1):91-5.
    View PubMed
  70. Zubair AC, Ali SA, Rees RC, Goepel JR, Winfield DA, Goyns MH. Analysis of the colonization of unirradiated and irradiated SCID mice by human lymphoma and non-malignant lymphoid cells. Leukemia & Lymphoma. 1996 Aug; 22(5-6):463-71.
    View PubMed